U.S. Markets close in 3 hrs 17 mins

NOVARTIS NAM. SF 0,50 (NOT.BE)


Berlin - Berlin Delayed Price. Currency in EUR
Add to watchlist
77.15-0.54 (-0.70%)
As of 5:45PM CEST. Market open.
Full screen
Previous Close77.69
Open77.51
Bid76.92 x 87300
Ask77.03 x 10000
Day's Range76.50 - 77.51
52 Week Range62.63 - 77.69
Volume869
Avg. Volume383
Market CapN/A
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Pharma Stock Roundup: NVS Scores with Positive Data, Shire ADHD Drug Gets FDA Nod
    Zacks5 hours ago

    Pharma Stock Roundup: NVS Scores with Positive Data, Shire ADHD Drug Gets FDA Nod

    All major pharma stocks were up this week with companies like Novartis (NVS) presenting positive data and others gaining FDA approval.

  • Reuters7 hours ago

    Novartis breast cancer drug Kisqali wins European panel backing

    A European Medicines Agency (EMA) panel recommended on Friday approving Novartis's Kisqali drug, bolstering the Swiss drugmaker's bid to challenge rival Pfizer's Ibrance against tough-to-treat breast cancer. The EMA's Committee for Medicinal Products for Human Use (CHMP) backed Kisqali in combination with hormone therapy as a first-line treatment for hormone receptor positive, human epidermal growth factor receptor-2 negative locally advanced or metastatic breast cancer. This latest CHMP opinion sets the stage for likely European Commission approval this year.

  • Novartis Pops To 5-Month High On Strong Trial In Heart Attack Survivors
    Investor's Business Daily21 hours ago

    Novartis Pops To 5-Month High On Strong Trial In Heart Attack Survivors

    Novartis stock rocketed to a five-month high Thursday after the drugmaker's anti-inflammatory proved successful in a trial.